GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBDPA.PFD) » Definitions » Notes Receivable

cbdMD (YCBDPA.PFD) Notes Receivable : $0.00 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is cbdMD Notes Receivable?

cbdMD's Notes Receivable for the quarter that ended in Mar. 2025 was $0.00 Mil.


cbdMD Notes Receivable Historical Data

The historical data trend for cbdMD's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD Notes Receivable Chart

cbdMD Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

cbdMD Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

cbdMD Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


cbdMD Notes Receivable Related Terms

Thank you for viewing the detailed overview of cbdMD's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


cbdMD Business Description

Traded in Other Exchanges
Address
2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

cbdMD Headlines

From GuruFocus

Q4 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2022 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

cbdMD Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

cbdMD Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

Q2 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2022 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024